Drug intelligence / Profile preview

heparin disaccharide iii-s

Development stage
Unknown
Modality
Small Molecules
01

Overview

Heparin disaccharide III-S is a synthetic or semi-synthetic disaccharide derived from the enzymatic digestion of heparan sulfate and heparin. It is a complex carbohydrate with notable anticoagulant and anti-inflammatory properties. This compound is used primarily in research to study protein-protein interactions and enzymatic activity related to glycosaminoglycans. Structurally, it contains two carbohydrate moieties linked together with multiple sulfate groups. Its mechanism of action involves mimicking specific sulfated motifs found in natural heparins that interact with proteins such as antithrombin III and platelet factor 4 (PF4), which are central to coagulation pathways[1][2][4][7]. Heparin disaccharide III-S itself is not approved for clinical use but serves as an important tool for dissecting structure-function relationships in anticoagulant drug development.

Other names
HEPARIN DISACCHARIDE III-S(2r,3r,4s)-2-(((2r,3s,4r,5r,6s)-4,6-dihydroxy-2-(hydroxymethyl)-5-(sulfonatoamino)oxan-3-yl)oxy)-4-hydroxy-3-(sulfonatooxy)-3,4-dihydro-2h-pyran-6-carboxylateCHEBI:42917
02

Targets

PF4 (Platelet factor 4)ATIII (Antithrombin III)

Beyond the preview

Go deeper on heparin disaccharide iii-s.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on heparin disaccharide iii-s.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call